Turner et al. found that the selective CerS inhibitor P053 specifically inhibited CerS1 expression, thereby reducing C18:0 ceramide levels in cells and mouse skeletal muscle and improving insulin resistance 104. This evidence concerns the gene CERS1 and Insulin resistance.